News that three different vaccines with high rates of efficacy in preventing COVID-19 are on their way has raised hopes. We can all use some cheerful news right about now. But the best medical evidence suggests we should temper our optimism.
Don’t throw away that mask or expect a short sprint to a world free of the pandemic, say experts. Nor will the vaccination of the Canadian general public really begin in earnest till the summer of 2021.
The oil and gas industry “likely won’t meaningfully reduce” its carbon pollution this decade without more government funding, according to a new Royal Bank of Canada report.
Giant solar farms have been widely heralded as great news for green energy in Canada. But is solar energy really sustainable? In the clamour to promote solar panels, there has been a conspicuous silence about the environmental costs of production and what happens to all those panels at end of life.
In our latest national survey, we asked how Canadians felt about two different tax ideas that have been discussed as part of an approach to helping pay for the costs of the pandemic. Here’s what we found.
The world’s nations are racing to rein in the climate crisis while maintaining strong economies. Troublingly, Canada is far behind in this time-critical race to build a low-carbon economy. Our decades of foot-dragging have put both our future prosperity and our climate at risk.
Climate vulnerable forum push for specifics as 151 countries promise tougher Paris targets
NOVEMBER 23, 2020
While more than 150 countries have confirmed their Paris Agreement commitments to introduce more ambitious climate plans by the end of this year, the Climate Vulnerable Forum is warning those promises may not be enough to avert the worst effects of the climate crisis in the countries it affects first and worst.
Canada once had a publicly owned pharmaceutical company that could have made a difference in the current coronavirus crisis — except that we sold it.
Connaught Labs was a superstar in global medicine. For seven decades, this publicly owned Canadian company performed brilliantly on the national and international stage, contributing to medical breakthroughs and developing affordable treatments and vaccines for deadly diseases.
